Go Pro
NYSE:VTR

Ventas Q2 2026 Earnings Report

Ventas logo
$100.61 +2.69 (+2.75%)
Closing price 07/24/2026 03:59 PM Eastern
Extended Trading
$101.61 +1.00 (+0.99%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ventas EPS Results

Actual EPS
N/A
Consensus EPS
$0.14
Beat/Miss
N/A
One Year Ago EPS
N/A

Ventas Revenue Results

Actual Revenue
N/A
Expected Revenue
$1.68 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Ventas Announcement Details

Quarter
Q2 2026
Time
After Market Closes
Conference Call Date
Thursday, July 30, 2026
Conference Call Time
10:00AM ET

Conference Call Resources

Ventas Earnings Headlines

Wells Fargo Keeps Their Buy Rating on Ventas (VTR)
ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I.
Jeff Brown and Marc Chaikin - two investors who spotted Nvidia a decade ago - are now pointing to Elon Musk's latest AI patent as the catalyst behind their next major call. They say a market pattern with a 100% historical track record is converging with this new breakthrough by end of month. The last time conditions aligned like this, investors had the chance to turn $10,000 into as much as $350,000 in roughly 12 months. Brown and Chaikin have released the full details for investors who want to get ahead of it.tc pixel
BMO Capital Remains a Buy on Ventas (VTR)
See More Ventas Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ventas? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ventas and other key companies, straight to your email.

About Ventas

Ventas (NYSE:VTR) (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity. The company leases space to a range of tenants that include senior living operators, healthcare systems, and research organizations, and it pursues a mix of ownership structures such as wholly owned properties and joint ventures. In addition to traditional real estate ownership, Ventas has historically provided structured financing and capital solutions to healthcare operators as part of its broader strategy to support operator stability and portfolio performance.

Founded in the late 1990s, Ventas has grown into a large, publicly traded REIT focused primarily on North American healthcare real estate, with additional selective investments in other developed markets. The company emphasizes portfolio diversification across property types, geographies and tenant relationships, and it pursues acquisitions, dispositions and strategic partnerships to reposition assets and create long-term value. Ventas is overseen by an experienced management team and board of directors that guide its capital allocation, risk management and operational strategies in the healthcare real estate sector.

View Ventas Profile